NCT00215644 2018-11-02
MATRIX EG
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
Clinical Trials
4 trialsNCT00111839 2018-04-06
Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
EMD Serono
Phase 2 Completed
NCT00073541 2017-01-20
A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer
EMD Serono
Phase 2 Completed
NCT00113581 2014-02-19
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer
Merck KGaA, Darmstadt, Germany
Phase 1 Completed